← Evidence map

TrialDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2025

Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac ®) versus branded tacrolimus (Prograf ®) in de novo liver transplant patients: a randomized clinical trial.

Mojtaba Shafiekhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41134494